Aldeyra Therapeutics (ALDX) has released an update.
Aldeyra Therapeutics’ CEO will virtually address the Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 13, 2024, discussing the progress of their clinical and regulatory affairs for their product candidates. The presentation materials will be available for reference, providing a condensed overview of information pertinent to investors and stakeholders. However, Aldeyra does not consider the presentation itself as material information and has no obligation to update its contents post-disclosure.
For further insights into ALDX stock, check out TipRanks’ Stock Analysis page.
